Intellia Therapeutics Inc buy melinda
Start price
08.03.18
/
50%
€28.31
Target price
10.09.18
€68.55
Performance (%)
-13.22%
End price
10.09.18
€24.57
Summary
This prediction ended on 10.09.18 with a price of €24.57. The prediction for Intellia Therapeutics Inc disappointed with a performance of -13.22%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | -3.654% | -3.654% | 8.984% | -71.024% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
According to melinda what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 13/03 | 20.50 Präsentation
mehr
$ NTLA mit einem Outperform bei JMP Initiiert & $ 76 PT
(Laufzeit überschritten)
Stopped prediction by melinda for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€18.68
21.05.20
21.05.20
€30.00
04.11.21
04.11.21
531.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
